Smiths Medical plans to distribute its CADD infusion systems to non-hospital-based providers through a preferred partnership with Medical Specialties Distributors, the company reported today.
As part of its new distribution model, Smiths will also make its infusion pumps and sets available to providers outside of the hospital setting through InfuSystem (NYSE:INFU) and Integrated Medical Systems.
The company touted its new model as simplifying the way that its customers place orders and receive CADD infusion therapy products from Smiths.
“This new model will enhance our ability to focus on expanding our technologies, and bringing enhanced solutions to market,” Carl Stamp, VP of global marketing and strategy, said in prepared remarks. “Selecting MSD as our preferred distribution partner provides a single-source service model, improving patient satisfaction and lowering the total cost of care.”
“MSD provides the widest purchase options to meet the business needs for infusion providers,” Keith Crawford, MSD’s chief strategy officer, added. “Smiths Medical’s infusion systems combined with our distribution, device, and technology offers best in class solutions for the customers we serve.”
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.